Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense.

Trial Profile

Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jul 2015

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary)
  • Indications Allergic rhinoconjunctivitis; Grass pollen hypersensitivity
  • Focus Adverse reactions
  • Sponsors ALK-Abello
  • Most Recent Events

    • 29 Mar 2012 Actual patient number 236 adde as reported by ClinicalTrials.gov.
    • 29 Mar 2012 Actual end date Feb 2012 added as reported by ClinicalTrials.gov.
    • 29 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top